Results 21 to 30 of about 685,817 (173)

Long-term clinical course and prognosis of vaccine-related persistent itching nodules (1997–2019): An observational study

Vaccine: X, 2022
Background: Vaccines adsorbed to aluminium can induce long-lasting intensely itching subcutaneous nodules (granulomas) at the injection site as well as contact allergy to aluminium. In clinical trials of a new acellular pertussis vaccine performed in the
Anette Gente Lidholm, Annica Inerot, Martin Gillstedt, Elisabet Bergfors, Birger Trollfors   +4 more
doaj   +1 more source

Seroprevalence of antibodies against diphtheria, tetanus, and pertussis among healthy Thai adolescents

International Journal of Infectious Diseases, 2020
Objective: To determine the seroprevalence of antibodies against of diphtheria, tetanus, and pertussis among Thai adolescents. Methods: A cross-sectional study was conducted among Thai adolescents aged 11–20 years who had completed five doses of ...
Pimpika Hanvatananukul, Chanidapa Prasarakee, Saowalak Sarachai, Linda Aurpibul, Kamolrawee Sintupat, Ratchaneekorn Khampan, Jutamad Saheng, Tavitiya Sudjaritruk   +7 more
doaj   +1 more source

Lack of association between mannose binding lectin and antibody responses after acellular pertussis vaccinations. [PDF]

PLoS ONE, 2014
BACKGROUND: Mannose-binding lectin (MBL) is one of the key molecules in innate immunity and its role in human vaccine responses is poorly known. This study aimed to investigate the possible association of MBL polymorphisms with antibody production after ...
Kirsi Gröndahl-Yli-Hannuksela, Juho Vuononvirta, Ville Peltola, Jussi Mertsola, Qiushui He   +4 more
doaj   +1 more source

Systematic Evaluation of the Distribution of Immune Cells following Subcutaneous Administration of Haemophilus Influenzae Type B Vaccine to Mice

Diseases, 2023
The Haemophilus influenzae type B (Hib) conjugate vaccine is the most effective way to prevent Hib infection in infants and young children, and it is designed to induce the production of antibodies against polyribosylribitol phosphate (PRP) to protect ...
Yao He, Yuxiu Zhao, Hongyang Liang, Xue Wang, Haoyue Lan, Dongyang Tian, Yan Li, Hui Wang   +7 more
doaj   +1 more source

Acellular pertussis vaccines effectiveness over time: A systematic review, meta-analysis and modeling study.

PLoS ONE, 2018
BackgroundAcellular pertussis vaccine studies postulate that waning protection, particularly after the adolescent booster, is a major contributor to the increasing US pertussis incidence.
Ayman Chit, Hossein Zivaripiran, Thomas Shin, Jason K H Lee, Antigona Tomovici, Denis Macina, David R Johnson, Michael D Decker, Jianhong Wu   +8 more
doaj   +1 more source

Safety and Immunogenicity of a Fully Liquid Vaccine Containing Five-Component Pertussis-Diphtheria-Tetanus-Inactivated Poliomyelitis-Haemophilus influenzae Type B Conjugate Vaccines Administered at Two, Four, Six and 18 Months of Age

Canadian Journal of Infectious Diseases and Medical Microbiology, 2007
OBJECTIVE: The safety, immunogenicity and lot consistency of a fully liquid, five-component acellular pertussis combination vaccine, comprised of diphteria, tetanus and acellular pertussis, inactivated polio vaccine, Haemophilus influenzae type b (DTaP ...
Ronald Gold, Luis Barreto, Santiago Ferro, John Thippawong, Roland Guasparini, William Meekison, Margaret Russell, Elaine Mills, Dana Harrison, Pierre Lavigne   +9 more
doaj   +1 more source

Acellular Pertussis Vaccine Effectiveness Over Time

Pediatrics, 2019
Compared with children fully DTaP vaccinated, unvaccinated and undervaccinated children were at a greater risk of pertussis. However, most pertussis cases occurred among age-appropriately vaccinated children.
O. Zerbo, J. Bartlett, Kristin Goddard, B. Fireman, E. Lewis, N. Klein   +5 more
semanticscholar   +1 more source

Pertussis toxin neutralizing antibody response after an acellular booster vaccination in Dutch and Finnish participants of different age groups

Emerging Microbes and Infections, 2022
Pertussis incidence has increased in many countries and the disease occurs among all age groups, suggesting the need for booster immunizations through life. In addition to determining the concentration of anti-pertussis toxin (PT) antibodies, the ability
Aapo Knuutila, Pauline Versteegen, Alex-Mikael Barkoff, Pieter van Gageldonk, Jussi Mertsola, Guy Berbers, Qiushui He   +6 more
doaj   +1 more source

Intranasal acellular pertussis vaccine provides mucosal immunity and protects mice from Bordetella pertussis

npj Vaccines, 2019
Current acellular pertussis vaccines fall short of optimal protection against the human respiratory pathogen Bordetella pertussis resulting in increased incidence of a previously controlled vaccine- preventable disease.
Dylan T. Boehm, M. A. Wolf, Jesse M. Hall, Ting Y. Wong, Emel Sen-Kilic, Hayden Basinger, S. Dziadowicz, Maria de la Paz Gutierrez, Catherine B. Blackwood, Shelby D. Bradford, Katherine A. Begley, William T. Witt, M. Varney, M. Barbier, F. Damron   +14 more
semanticscholar   +1 more source

Pertussis immunisation in infancy and atopic outcomes: A protocol for a population-based cohort study using linked administrative data.

PLoS ONE, 2021
IntroductionThe burden of IgE-mediated food allergy in Australian born children is reported to be among the highest globally. This illness shares risk factors and frequently coexists with asthma, one of the most common noncommunicable diseases of ...
Gladymar Pérez Chacón, Parveen Fathima, Mark Jones, Rosanne Barnes, Peter C Richmond, Heather F Gidding, Hannah C Moore, Thomas L Snelling   +7 more
doaj   +2 more sources